SUBSCRIBE
SUBSCRIBE

Skyhawk Therapeutics

NEWS
Business
Skyhawk Therapeutics Partners with Merck to Discover and Develop RNA-Binding Molecules
Skyhawk and Merck will partner to discover and develop innovative RNA-binding small molecules that can form treatments for neurological diseases and cancer.
July 8, 2019
 · 
2 min read
 · 
Alex Keown
Job Trends
BioSpace Movers and Shakers: Feb. 15
Pharma and biotech companies strengthen their leadership teams with new hires and appointments at Cadent, bluebird, Abeona, Sanofi, and more.
February 14, 2019
 · 
5 min read
 · 
Alex Keown
Business
Top 20 Life Science Startups to Watch in 2019
BioSpace is proud to present its NextGen Bio “Class of 2019,” a list of 20 up-and-coming life science companies in North America that launched* no earlier than 2017.
November 6, 2018
 · 
12 min read
 · 
Mark Terry
Load More
AWARDS
  • NextGen Class of 2019
JOBS
IN THE PRESS
Drug Development
Skyhawk Therapeutics Has Advanced to the Multiple Ascending Dose Portion of its Phase 1 Study evaluating SKY-0515, a RNA-Targeting Small Molecule for Huntington’s Disease
February 28, 2024
 · 
3 min read
Genetown
Skyhawk Therapeutics Receives HREC Approval for a Phase 1 Study of its SKY-0515 RNA-Targeting Small Molecule for Huntington’s Disease
October 23, 2023
 · 
3 min read
Business
Skyhawk Announces Collaboration Agreement with Sanofi for Oncology and Immunology Targets
July 5, 2022
 · 
2 min read
Genetown
Skyhawk Therapeutics Completes New Investment Round
September 14, 2021
 · 
1 min read
Business
Aragen Announces Partnership with Skyhawk Therapeutics, Aimed at Developing Novel Small Molecule Therapeutics that Correct RNA Expression
July 15, 2021
 · 
1 min read
Business
Skyhawk Therapeutics Expands Leadership Team, Appointing Elliot Ehrich MD as President and Graeme Smith PhD as SVP NonClinical Development
April 13, 2021
 · 
2 min read
Business
Skyhawk Therapeutics Expands Leadership Team with Chief Medical Officer and Head of Chemistry, and adds to its Scientific Advisory Board
October 5, 2020
 · 
4 min read
Business
Skyhawk Therapeutics Announces Expansion of its Collaboration Agreement with Merck to Discover and Develop Novel Small Molecules that Modulate RNA Splicing
May 12, 2020
 · 
2 min read
Business
Experienced Business Leader in Biopharmaceutical Industry Joins as Chief Operating Officer at Skyhawk Therapeutics
February 24, 2020
 · 
2 min read
Business
Skyhawk Therapeutics Announces a Second Multi-Target Collaboration Agreement with Celgene to Discover and Develop Novel Small Molecules that Modulate RNA Splicing
November 12, 2019
 · 
2 min read
Load More